Loading
Latest filing published 22 Dec 2025 for CITIUS ONCOLOGY, INC..
No signal scores available.
Robert Joseph Smith discloses dealings in Citius Oncology, Inc. to SEC (Form 4). The record holds 3 filings, all for trades on 19 September 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 22 December 2025, reports a share grant in Citius Oncology, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations